Premium
Discovery of a New Class of Inhibitors of Vaccinia Virus Based on (−)‐Borneol from Abies sibirica and (+)‐Camphor
Author(s) -
Sokolova Anastasiya S.,
Yarovaya Olga I.,
Bormotov Nikolay I.,
Shishkina Larisa N.,
Salakhutdinov Nariman F.
Publication year - 2018
Publication title -
chemistry and biodiversity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 70
eISSN - 1612-1880
pISSN - 1612-1872
DOI - 10.1002/cbdv.201800153
Subject(s) - chemistry , morpholine , camphor , heptane , vaccinia , cytotoxicity , bioassay , amide , stereochemistry , alkyne , virus , inhibitory postsynaptic potential , in vitro , combinatorial chemistry , organic chemistry , biochemistry , virology , catalysis , genetics , biology , gene , recombinant dna , neuroscience
A series of the bornyl ester/amide derivatives with N‐containing heterocycles were designed and synthesized as vaccinia virus ( VV ) inhibitors. Bioassay results showed that among the designed compounds, derivatives 6 , 13 , 14 , 34 , 36 and 37 showed the best inhibitory activity against VV with the IC 50 values of 12.9, 17.9, 3.4, 2.5, 12.5 and 7.5 μ m , respectively, and good cytotoxicity. The primary structure–activity relationship ( SAR ) study suggested that the combination of a saturated N‐heterocycle, such as morpholine or 4‐methylpiperidine, and a 1,7,7‐trimethylbicyclo[2.2.1]heptane scaffold was favorable for antiviral activity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom